Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen.

The flavonoids are a group of naturally-occurring, low molecular weight compounds that are widespread in plants. Representatives of several different classes of flavonoids were tested for their effects on the proliferation of an estrogen receptor-positive human breast cancer cell line, MCF-7. The IC50S (concentration at which cell proliferation was inhibited by 50%), based on [3H]thymidine incorporation, ranged from 4.2 to 18.0 micrograms/mL. The cells were viable at these concentrations. The possibility that flavonoids may block cell proliferation by binding to the estrogen receptor was explored. The cells were depleted of endogenous steroids and incubated with individual flavonoids at their IC50 concentration. Half of the cells were exposed to an excess concentration of 17 beta-estradiol to see if this affected antiproliferation by the flavonoids. Of the flavonoids tested, only the inhibition of cell proliferation by genistein was reversed with the addition of excess, competing estrogen. Baicalein, galangin, hesperetin, naringenin and quercetin apparently exert their antiproliferative activity via some other mechanism.

[1]  J. H. Clark,et al.  Heterogeneity of estrogen binding sites in the cytosol of the rat uterus. , 1978, The Journal of biological chemistry.

[2]  J. Levy,et al.  Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: inhibition by quercetin. , 1984, Biochemical and biophysical research communications.

[3]  D. Sheehan The Case for Expanded Phytoestrogen Research , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  V. Cody,et al.  Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. , 1989, Biochemical pharmacology.

[5]  J. Kellis,et al.  Inhibition of human estrogen synthetase (aromatase) by flavones. , 1984, Science.

[6]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[7]  R. Miksicek Estrogenic Flavonoids: Structural Requirements for Biological Activity , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  J. H. Clark,et al.  An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. , 1984, Cancer research.

[9]  D. Shutt The effects of plant oestrogens on animal reproduction. , 1976, Endeavour.

[10]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[11]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[12]  D. Ryan,et al.  Naturally-Occurring Estrogens in Plant Foodstuffs - A Review. , 1979, Journal of food protection.

[13]  J. H. Clark,et al.  Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response. , 1979, Endocrinology.

[14]  N Guthrie,et al.  Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. , 1996, Nutrition and cancer.

[15]  J. Nicolas,et al.  Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. , 1994, Cancer research.